Female Hypoactive Sexual Desire Disorder Therapeutics Market

Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, By Product Type (BP-101, Bremelanotide, Gepirone Hydrochloride ER, PVT-011, Others), By Application (Out-Patient, In-Patient), By Key Players (Emotional Brain BV, GlaxoSmithKline Plc, Palatin Technologies Inc, Pivot Pharmaceuticals Inc, Strategic Science & Technologies LLC), By Regional Outlook And Competitive Landscape Forecast To 2032

Report ID: RV219581 | Published: Dec 2023 | Historical Period: 2018-2021 | Pages: 162 | Price: $3260| Industry: Medical Care
50-Percent-Sale

To Learn More About This Report

Our Clients